ErmB-mediated erythromycin resistance in Streptococcus uberis from bovine mastitis

Veterinary Journal

Volumn 189, Issue 3, 2011, Pages 356-358

  Haenni, Marisa ^a   Saras, Estelle ^a   Chaussière, Sophie ^b   Treilles, Michaël ^b   Madec, Jean Yves ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b Laboratoire Départemental d'Analyses LDA50   (France)

Author keywords

Antibiotic resistance; ErmB; LinB; Lincosamides; Macrolides; Mastitis; Streptococcus uberis

Indexed keywords

ERYTHROMYCIN; LINCOSAMIDE DERIVATIVE; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BOVINE MASTITIS; ERMB GENE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENOTYPE; LINB GENE; LNUD GENE; METHYLATION; NONHUMAN; PHENOTYPE; STREPTOCOCCUS UBERIS;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; FRANCE; GENES, BACTERIAL; GENOTYPE; LINCOSAMIDES; MACROLIDES; MASTITIS, BOVINE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PRISTINAMYCIN; STREPTOCOCCUS;

BOVINAE; STREPTOCOCCUS UBERIS;

EID: 80052847798     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.06.021     Document Type: Article

References (10)

1. Botrel M.-A., Haenni M., Morignat E., Sulpice P., Madec J.-Y., Calavas D. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France. Foodborne Pathogens and Disease 2010, 7:479-487.
2. Bozdogan B., Berrezouga L., Kuo M.S., Yurek D.A., Farley K.A., Stockman B.J., Leclercq R. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrobial Agents and Chemotherapy 1999, 43:925-929.
3. CA-SFM, 2008. Recommandations 2008 du Comité de l'antibiogramme de la Société Française de Microbiologie, pp. 1-49.
4. Desjardins M., Delgaty K.L., Ramotar K., Seetaram C., Toye B. Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results. Journal of Clinical Microbiology 2004, 42:5620-5623.
5. Fines M., Gueudin M., Ramon A., Leclercq R. In vitro selection of resistance to clindamycin related to alterations in the attenuator of the erm(TR) gene of Streptococcus pyogenes UCN1 inducibly resistant to erythromycin. Journal of Antimicrobial Chemotherapy 2001, 48:411-416.
6. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clinical Infectious Diseases 2002, 34:482-492.
7. McKenna S., Evans G. Macrolides: a Canadian Infectious Disease Society position paper. Canadian Journal of Infectious Diseases 2001, 12:218-231.
8. Petinaki E., Guerin-Faublee V., Pichereau V., Villers C., Achard A., Malbruny B., Leclercq R. Lincomycin resistance gene lnu(D) in Streptococcus uberis. Antimicrobial Agents and Chemotherapy 2008, 52:626-630.
9. Schmitt-Van de Leemput E., Zadoks R.N. Genotypic and phenotypic detection of macrolide and lincosamide resistance in Streptococcus uberis. Journal of Dairy Science 2007, 90:5089-5096.
10. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrobial Agents and Chemotherapy 1996, 40:2562-2566.